October 20
World Osteoporosis Day
One of the recommendations of doctors is to use HRT for more benefits as life and protection against the risks caused by menopause, such as osteoporosis.
Osteoporosis is a debilitating disease in which people lose calcium from bones due to increased risk of fragility fractures.
Experts say there are about 11 million women at risk of suffering or to have it, since this quantity is the number of women who are in menopause stage, ie between 44 and 60 years of age, stage in which the risk increases of osteoporosis.
That's why experts say that menopause protection against osteoporosis should start from the beginning of this stage, ie from the perimenopause (during menopause), and initiating the hormonal control , specifically estrogen, which causes bone loss becomes more severe after menopause.
bone protection is achieved through hormone replacement therapy (HRT), then to restore the hormone levels of women decreases the risk of fractures and hence to develop osteoporosis.
Studies have shown a benefit of the long-term hormone therapy (after 5 years of use, since the perimenopause) to reduce the rate of fractures by about 50%, provided an appropriate dose is administered to each woman's needs.
"The best results are obtained when TH is administered from the beginning of the decline of estrogen, this occurs from age 45. It has been found that during the first years of using HRT have an increased bone mineral density, "said Dr. Alfonso Murillo, president of the Mexican Association of Menopause.
Importantly, both the specialist and women should be aware of the importance of personalizing treatment and adjust the dose of hormone administered according to the stage where it is women. According to Dr. Murillo when a woman enters perimenopause is recommended that hormone replacement therapy is low dose, increasing certainty and better tolerance for those just beginning treatment.
"Hormone therapy with estrogen or combined with progestin is the treatment of choice for preventing and treating postmenopausal osteoporosis, provided that the therapy is administered by an appropriate period from the perimenopause. Among the low-dose hormone therapy, emphasizes the combination of estradiol and gestodene. Estradiol is an estrogen similar to that produced during the menstrual cycle of women, while gestodene progestin protects the endometrium and offers good control of the menstrual cycle, "adds Dr. Murillo.
Importantly, the benefits offered hormone therapy on quality of life of patients have been studied for many years. The new specific treatment for women in perimenopause, the answer to the concerns of various users and doctors about the possible risks that the use of higher doses of hormones can cause in women, and thus represent a significant advance in the treatment of menopause as well as protection against long-term risks of hormonal decline.
0 comments:
Post a Comment